Literature DB >> 34160555

Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines.

Lacey B Robinson1, Xiaoqing Fu1, Dean Hashimoto2, Paige Wickner3, Erica S Shenoy1, Adam B Landman3, Kimberly G Blumenthal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34160555      PMCID： PMC8223130          DOI： 10.1001/jamadermatol.2021.2114

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   11.816


× No keyword cloud information.
  26 in total

1.  Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy.

Authors:  Salma El-Behaedi; Spencer Ng; Parul K Goyal; Jennifer N Choi
Journal:  JAAD Case Rep       Date:  2022-09-02

2.  Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity.

Authors:  Sarah Edgerley; Samira Jeimy; Rongbo Zhu
Journal:  CMAJ       Date:  2022-06-13       Impact factor: 16.859

Review 3.  Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.

Authors:  Shuen-Iu Hung; Ivan Arni C Preclaro; Wen-Hung Chung; Chuang-Wei Wang
Journal:  Biomedicines       Date:  2022-05-28

Review 4.  A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.

Authors:  Farnoosh Seirafianpour; Homa Pourriyahi; Milad Gholizadeh Mesgarha; Arash Pour Mohammad; Zoha Shaka; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2022-04-11       Impact factor: 3.858

5.  Cancer patients and COVID-19 vaccination, from safety to protocol adherence: A real-life setting report.

Authors:  Haitam Lamtai; Saber Boutayeb; Hind Mrabti; Ibrahim El Ghissassi; Hassan Errihani
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

6.  Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).

Authors:  Sunmeet Sandhu; Anuj Bhatnagar; Harish Kumar; Prashant Kumar Dixit; Gourang Paliwal; Devinder Kumar Suhag; Chetan Patil; Debdeep Mitra
Journal:  Dermatol Ther       Date:  2021-10-05       Impact factor: 3.858

7.  Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adult.

Authors:  T Prarthana; S Bakshi; V Hanumanthu; U Nahar; D De
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-02-22       Impact factor: 6.166

Review 8.  Adverse Events and Safety of SARS-CoV-2 Vaccines: What's New and What's Next.

Authors:  Kristen B Corey; Grace Koo; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2022-05-10

Review 9.  Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.

Authors:  M Balogun; D Millette; V Yip; S A Chan; P Lee; N Gamal; N Hashim; D Phillips; M Walsh; P Trehan; L Hanna-Bashara; A Abdullah; A Wernham; S Tso
Journal:  Clin Exp Dermatol       Date:  2021-12-16       Impact factor: 4.481

10.  Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort study in healthcare workers.

Authors:  P Rerknimitr; T Puaratanaarunkon; C Wongtada; N Wittayabusarakam; S Krithin; L Paitoonpong; C Kumtornrut; S J Kerr; P Asawanonda; W Jantarabenjakul; J Klaewsongkram
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-29       Impact factor: 9.228
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.